# The Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal Men

> **NCT00696748** · PHASE3 · UNKNOWN · sponsor: **Russian Academy of Medical Sciences** · enrollment: 250 (estimated)

## Conditions studied

- Metabolic Syndrome
- Hypogonadism

## Interventions

- **DRUG:** Nebido (testosterone undecanoate)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00696748
- **Lead sponsor:** Russian Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-10
- **Primary completion:** 2009-01
- **Final completion:** 2010-12
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2008-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00696748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00696748, "The Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal Men". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00696748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*